Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCovenant Partners, LLC
Latest Disclosed Ownership7,542 shares
Latest Disclosed Value $ 1,039,816
Covenant Partners, LLC ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On January 26, 2026 - Covenant Partners, LLC filed a 13F-HR form disclosing ownership of 7,542 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $882,414 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 24, 2025 disclosing 7,542 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $912,582 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-26 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,542 0 0.00 1,040 7.45 0.3040
2025-10-24 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,542 0 0.00 967 6.03 0.2742
2025-07-30 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,542 0 0.00 913 8.57 0.2724
2025-05-13 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,542 0 0.00 841 14.60 0.2721
2025-02-14 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,542 -66 -0.87 734 -16.23 0.2262
2024-10-24 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,608 66 0.88 875 9.10 0.2547
2024-08-05 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,542 0 0.00 803 10.01 0.2441
2024-04-30 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,542 -307 -3.91 730 -7.95 0.2126
2024-02-20 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,849 -90 -1.13 793 -1.98 0.2500
2023-10-20 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,939 -36 -0.45 809 0.50 0.2936
2023-09-05 2023-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 7,975 126 1.61 805 11.36 0.2907
2023-08-11 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,975 126 805 0.2907
2023-04-19 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,849 -801 -9.26 722 -7.91 0.2769
2023-02-17 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,650 -1,809 -17.30 785 -1.38 0.3157
2022-11-10 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 10,459 0 0.00 795 -10.07 0.3875
2022-07-27 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 10,459 -3,102 -22.87 884 -25.71 0.4092
2022-05-16 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 13,561 2,455 22.11 1,190 22.55 0.4743
2022-02-15 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 11,106 -3,709 -25.04 971 -19.88 0.3598
2021-11-12 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 14,815 3,709 33.40 1,212 19.64 0.4763
2021-08-02 2021-06-30 13F NOVARTIS AG F SPONSORED ADR 1 ADR REPS 1 ORD SHS NVS 66987V109 11,106 -3,282 -22.81 1,013 -17.64 0.3822
2021-05-11 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 14,388 -4,669 -24.50 1,230 -31.67 0.4896
2021-02-10 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 19,057 9,055 90.53 1,800 106.90 0.7619
2020-11-10 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 10,002 918 10.11 870 9.71 0.4211
2020-08-17 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 9,084 -1,497 -14.15 793 -9.06 0.3679
2020-05-15 2020-03-31 13F NOVARTIS AG F SPONSORED ADR 1 ADR REPS 1 ORD SHS SPONSORED ADR 66987V109 10,581 3,870 57.67 872 37.32 0.4653
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 6,711 -5,256 -43.92 635 -38.94 0.2964
2019-11-14 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 11,967 5,256 78.32 1,040 69.66 0.5521
2019-08-15 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,711 -1,202 -15.19 613 -19.45 0.3256
2019-05-16 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 7,913 1,840 30.30 761 46.07 0.4231
2019-02-14 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 6,073 6,073 521 0.2492
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.